Withdrawal of inhaled corticosteroids in individuals with COPD - a systematic review and comment on trial methodology

Respiratory Research

Volumn 12, Issue , 2011, Pages

  Nadeem, Nighat J ^a   Taylor, Stephanie J C ^a   Eldridge, Sandra M ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; CORTICOSTEROID; FLUTICASONE; IPRATROPIUM BROMIDE; PLACEBO; SALMETEROL;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; CLINICAL RESEARCH; DATA EXTRACTION; DISEASE EXACERBATION; DRUG WITHDRAWAL; HUMAN; METHODOLOGY; OUTCOME ASSESSMENT; REVIEW; SYSTEMATIC ERROR; SYSTEMATIC REVIEW; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; INHALATIONAL DRUG ADMINISTRATION; META ANALYSIS; PATHOPHYSIOLOGY; WITHDRAWAL SYNDROME;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; CLINICAL TRIALS AS TOPIC; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 80051593508     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-12-107     Document Type: Review

References (24)

1. Global Initiative for Obstructive Lung Disease Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2006, (accessed 22 April 2007), Global Initiative for Obstructive Lung Disease., http://www.goldcopd.com/
2. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997, 349:1498-1504. 10.1016/S0140-6736(96)07492-2, 9167458.
3. National Institute for Clinical Excellence Chronic obstructive pulmonary disease. 2004, (last accessed 29 July 2011), National Institute for Clinical Excellence., http://www.nice.org.uk/CG101
4. British Thoracic Society (BTS) Burden of Lung Disease Report. 2006, 2, (last accessed 29 July 2011)., http://www.brit-thoracic.org.uk/delivery-of-respiratory-care/burden-of-lung-disease-reports.aspx
5. Calverley PMA, Anderson JA, Bartolome C, Ferguson GT, Jenkins C, Jones PW, Vestbo J. Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease. N Engl J Med 2007, 356:775-89. 10.1056/NEJMoa063070, 17314337.
6. Yang IA, Fong K, Sim EHA, Black PN, Lasserson TJ. Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2007, (2). Art. No.: CD002991.
7. Celli BR, Thomas NE, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, Vestbo J, Knobil K, Yates JC, Calverley PM. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med 2008, 178(4):332-8. 10.1164/rccm.200712-1869OC, 18511702.
8. Drummond MB, Dasenbrook EC, Pitz MW, Murphy DJ, Fan E. Inhaled Corticosteroids in Patients With Stable Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis. JAMA 2008, 300:2407-2416. 10.1001/jama.2008.717, 19033591.
9. Cumming RG, Mitchell P, Leeder SR. Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med 1997, 337:8-14. 10.1056/NEJM199707033370102, 9203425.
10. Garbe E, LeLorier J, Boivin J, Suissa S. Inhaled and nasal glucocorticocoids and the risk of ocular hypertension or open-angle glaucoma. JAMA 1997, 277:722-727. 10.1001/jama.277.9.722, 9042844.
11. Weatherall M, James K, Clay J, Perrin K, Masoli M, Wijesinghe M, Beasley R. Dose response relationship for risk of non-vertebral fracture with inhaled corticosteroids. Clin Exp Allergy 2008, 38(9):1451-145. 10.1111/j.1365-2222.2008.03029.x, 18537983.
12. American Thoracic Society Standards for the diagnosis and management of patients with COPD. 2004, (last accessed 29 July 2011), American Thoracic Society., http://www.thoracic.org/clinical/copd-guidelines/
13. Higgins JPT, Green S, . editors Cochrane Handbook for Systematic Reviews of Interventions 5.0.2. (last accessed 29 July 2011), [updated September 2009], editors., http://www.cochrane.org/training/cochrane-handbook
14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7(3):177-88. 10.1016/0197-2456(86)90046-2, 3802833.
15. Choudhury AB, Dawson CM, Kilvington HE, Eldridge S, James W, Wedzicha JA, Feder GS, Criffiths CJ. Withdrawal of inhaled corticosteroids in people with COPD in primary care: a randomised controlled trial Respiratory Research. 2007, 8:93.
16. van der Valk P, Monninkhof E, van der Palen J, Zielhuis G, van Herwaarden C. Effects of discontinuing inhaled corticosteroids in patients with chronic obstructive pulmonary disease. The COPE study. Am J Respir Crit Care Med 2002, 166:1358-1363. 10.1164/rccm.200206-512OC, 12406823.
17. Wouters EFM, Postma DS, Fokkenst B, Hop WCJ, Prins J, Kuipers AF, Pasma HR, Hensing CAJ, Creutzberg EC. for the COSMIC (COPD and Seretide: a multi-centre intervention and characterisation) study group. Thorax 2005, 60:480-487. 10.1136/thx.2004.034280, 1747438, 15923248.
18. O'Brien A, Russo-Magno P, Karki A, Hiranniramol S, Hardin M, Kaszuba M, Sherman C, Rounds S. Effects of withdrawal of inhaled steroids in men with severe irreversible airflow obstruction. Am J Respir Crit Care Med 2001, 164(3):365-371.
19. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991, 85(Suppl B):25-31. discussion 33-7.
20. Agarwal R, Aggarwal AN, Gupta D, Jindal SK. Inhaled corticosteroids vs placebo for preventing COPD exacerbations: a systematic review and metaregression of randomized controlled trials. Chest 2010, 137(2):318-25. 10.1378/chest.09-1305, 19783669.
21. Moher D, Schulz KF, Altman DG, . CONSORT Group (Consolidated Standards of Reporting Trials) The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. J Am Podiatr Med Assoc 2001, 91(8):437-42. CONSORT Group (Consolidated Standards of Reporting Trials).
22. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. Journal of Chronic Diseases 1967, 20:637-648. 10.1016/0021-9681(67)90041-0, 4860352.
23. Peto R, Collins R, Gray R. Large-scale randomized evidence: large, simple trials and overviews of trials. Journal of Clinical Epidemiology 1995, 48(1):23-40. 10.1016/0895-4356(94)00150-O, 7853045.
24. Dunn G, Maracy M, Dowrick C, Ayuso-Mateos JL, Dalgard OS, Page H, Lehtinen V, Casey P, Vazquez-Barquero JL, Wilkinson G, Wilkinson C. ODIN group Estimating psychological treatment effects from a randomised controlled trial with both non-compliance and loss to follow-up. Br J Psychiatry 2003, 183:323-31. 10.1192/bjp.183.4.323, 14519610, ODIN group.